News | October 22, 2008

Sweden Implants First CardioWest Bridge-to-Transplant Artificial Heart

October 23, 2008 - SynCardia announced that on Oct. 15, Dr. Lars Wiklund, chief of cardiothoracic surgery at Sahlgrenska University Hospital in Gothenburg, Sweden, led a surgical team in implanting the CardioWest temporary total artificial heart into a 31-year-old male patient, making it the first Swedish implant of the device.

Dr. Ulf Kjellman, head of the hospital’s ventricular assist device (VAD) program, performed the implant.

“If it weren’t for the CardioWest artificial heart, this patient would have died,” said Dr. Kjellman. “Both sides of his heart were failing. He needed a heart transplant to survive, but no donor heart was available. His only option was for us to implant the CardioWest artificial heart as a bridge-to-transplant. The artificial heart will make him a stronger and healthier transplant candidate while he waits for a matching donor heart.”

In some countries in Europe, artificial heart patients can wait up to two years for a matching donor heart. Since July 16, 2006, stable CardioWest patients in Europe have been able to recover at home thanks to the CE-approved portable driver.

During Q4 2008, SynCardia will apply to the FDA to conduct an IDE clinical study of the Companion Driver System in the U.S. and will also apply for CE approval in Europe. The Companion Driver is designed for use in both the hospital and at home. SynCardia projects a 400 percent increase in the number of patients benefiting from the CardioWest artificial heart in the 24 months following regulatory approvals.

Sweden joins Germany, France, Austria and Italy as the fifth European country with a hospital certified to implant the CardioWest artificial heart.

For more information: www.syncardia.com

Related Content

Sponsored Content | Videos | Cardiovascular Ultrasound| July 19, 2017
This video educational session, provided in partnership with the American Society of Echocardiography (ASE), is title
Pre-PCI Impella 2.5 Insertion Improves Survival in Left Main Coronary Artery Heart Attacks
News | Ventricular Assist Devices (VAD)| June 30, 2017
Abiomed Inc. announced the recent publication of a peer-reviewed retrospective study on hemodynamic support with the...
Italian Boy Becomes Youngest Patient Bridged to Transplant With SynCardia Total Artificial Heart

Andrei, 12, is the world’s youngest patient to be bridged to transplant with the SynCardia Total Artificial Heart. He is pictured after his heart transplant with his surgeon, Antonio Amodeo, M.D., at Bambino Gesù Children’s Hospital in Rome, Italy. Photo courtesy of Business Wire.

News | Congenital Heart| June 22, 2017
A 12-year-old boy at Bambino Gesù Children’s Hospital in Rome, Italy, has become the world’s youngest patient to be...
Abiomed Impella CP pVAD, third-generation CP
Technology | Hemodynamic Support Devices| June 12, 2017
June 12, 2017 — Abiomed Inc.
tandemLife Tandemheart priming tray cleared by FDA
Technology | Hemodynamic Support Devices| June 12, 2017
June 12, 2017 — TandemLife began its commercial launch of the TandemLife Priming Tray, a new product designed to simp
Sponsored Content | Videos | Cardiovascular Ultrasound| May 26, 2017
This video, provided in partnership with the American Society of Echocardiography (ASE), is titled "Intraoperative Tr
Impella CP study to investigate door to left ventricular unloading time
News | May 09, 2017
May 9, 2017 — The first patient has been enrolled in the U.S.
Heartware HVAD recall for its ventricular assist device from Medtronic
Feature | Ventricular Assist Devices (VAD)| May 05, 2017
May 5, 2017 — Medtronic Mechanical Circulatory Support is expanding its recall of its HeartWare Ventricular Assist De
the Impella pVAD improves survival, mortality in AMI heart attack with cardiogenic shock

Early use of the Impella percutaneous ventricular assist device prior to angioplasty may significantly improve survival for patients in cardiogenic shock.

Feature | Hemodynamic Support Devices| April 28, 2017 | Dave Fornell
Recent clinical study data presented at the American College of Cardiology (ACC) 2017 meeting show new treatment prot
Sponsored Content | Videos | Ventricular Assist Devices (VAD)| April 14, 2017
A discussion with William O'Neill, M.D., FACC, FSCAI, medical director of the Center for Structural Heart Disease at
Overlay Init